| Title | [Basics of Gerontopharmaceutic Therapy and the Therapy of Agitation in old age.] | | Author(s) | Wettstein A | | Institution | Stadtärztlicher Dienst, Zürich. | | Source | Praxis (Bern 1994) 2009 Oct 21; 98(21):1211-7. | | Abstract | The biggest problem of gerontopharmaceutic therapy is polypharmacy, because it potentiates side effects and malcompliance. Best practice today includes instruction of long time patients in medication self management, which includes regular use of detailed taken medication lists. In gerontopharmaceutic therapy the following substances should be avoided: anticholinergics, dopaminreceptor stimulants, long acting oral antidiabetics, benzodiazepine (other then for substitution in low dose dependency, in anaesthesia or in palliative situations) and neuroleptics (other then for psychotic symptoms). In unspecific agitation with or without dementia the measure of first choice is adaption of the milieu, which may be supported by the prescription of a sedative non tricyclic antidepressiv medication. | | Language | ger | | Pub Type(s) | English Abstract
Journal Article
| | PubMed ID | 19844879 |
|
